Literature DB >> 33169673

Integrated analysis of the functions of RNA binding proteins in clear cell renal cell carcinoma.

Xiaoliang Hua1, Juan Chen2, Shengdong Ge1, Haibing Xiao1, Li Zhang3, Chaozhao Liang4.   

Abstract

RNA binding proteins (RBPs) dysregulation is involved in the processes of various tumors. However, the roles of RBPs in clear cell renal cell carcinoma (ccRCC) remain poorly understand. In present study, we first performed consensus clustering and identified two clusters, of which cluster 2 was closely correlated with the malignancy of ccRCC. Differentially expressed RBPs between normal and tumor tissues were obtained, comprising 71 up-regulated and 44 down-regulated ones. Then, ten hub genes were selected and validated using The Human Protein Atlas database and receiver operating characteristic curves, showing good diagnostic value for cancers. Besides, we identified ten RBPs with the most useful prognostic values, and were used to construct a risk score model. The model could be used to stratify patients with different prognosis and phenotype distributions. The model showed good performance and can be used as a complementation for clinical factors to guide clinical practice in the future.
Copyright © 2020. Published by Elsevier Inc.

Entities:  

Keywords:  Bioinformatics; Biomarker; Clear cell renal cell carcinoma; Prognostic model; RNA binding proteins

Mesh:

Substances:

Year:  2020        PMID: 33169673     DOI: 10.1016/j.ygeno.2020.10.016

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  2 in total

1.  Transcriptome Analyses Identify an RNA Binding Protein Related Prognostic Model for Clear Cell Renal Cell Carcinoma.

Authors:  Yue Wu; Xian Wei; Huan Feng; Bintao Hu; Bo Liu; Yang Luan; Yajun Ruan; Xiaming Liu; Zhuo Liu; Shaogang Wang; Jihong Liu; Tao Wang
Journal:  Front Genet       Date:  2021-01-07       Impact factor: 4.599

2.  Construction and validation of a prognostic model of RNA binding proteins in clear cell renal carcinoma.

Authors:  Wenkai Han; Bohao Fan; Yongsheng Huang; Xiongbao Wang; Zhao Zhang; Gangli Gu; Zhao Liu
Journal:  BMC Nephrol       Date:  2022-05-05       Impact factor: 2.585

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.